GGrantIndex
← Search

Developing a mobile-health intervention to reduce problematic alcohol use in young adults with ADHD - Supplement

$64,996K23FY2023AANIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

Linked publications & trials

Abstract

PROJECT SUMMARY/ABSTRACT Dr. Traci Kennedy, PI of the proposed K23, is a clinical scientist whose long-term goal is to lead a program of research on developing and testing interventions to reduce problematic alcohol use among vulnerable young people, especially young adults with Attention-Deficit/Hyperactivity Disorder (ADHD). The purpose of this administrative supplement is to support Dr. Kennedy’s transition from a mentored career development K23 award to research independence in the aftermath of her recent critical life event. This supplement support will facilitate the successful and timely completion of the goals of the parent K23 project, and will therefore help ensure the continuity of Dr. Kennedy’s research during this critical juncture in her career by providing funds to support additional staff effort and resources. Together with personnel and resources provided by the parent award, the supplemental effort of a research specialist, study clinician, computer programmer, and administrative support specialist, as well as additional advertising to hasten participant recruitment, and trainings and supplies in part to rapidly increase the research specialist’s skills, will expedite data collection during the supplement period and allow Dr. Kennedy to devote more of her effort to activities that directly accomplish the study’s primary research aims (e.g., data analysis, intervention development) and training aims (e.g., manuscript preparation, directed readings, conference presentations) while research staff undertake greater effort toward day-to-day study coordination and administrative tasks. As a result, the pace of the parent K23 project, which has slowed by approximately 3 months due to delays related to Dr. Kennedy’s recent critical life event, will realign with the originally proposed timeline by the end of the one-year administrative supplement period. In the subsequent year, this resumption of the original project timeline will result in the timely transition to the final phase of the parent K23 project, Dr. Kennedy’s successful submission of an R01 application based on K23 data, and Dr. Kennedy’s ultimate transition to an independent research career.

View original record on NIH RePORTER →